TABLE 2.
Impact of the FUS treatment through SUVr asymmetry analysis.
| Treated/untreated hippocampus/EC asymmetry |
|||
| Patient ID | Baselinea | Post-treatmentb | % changec |
| 1 | 1.041 | 1.007 | −3.35% |
| 2 | 1.023 | 0.959 | −6.23% |
| 3 | 1.055 | 1.026 | −2.72% |
| 4 | 0.989 | 0.943 | −4.69% |
| 5 | 0.864 | 0.836 | −3.25% |
| 6 | 0.977 | 0.879 | −10.05% |
Asymmetry is computed as the ratio of SUVr (cerebellum as the reference region) for the treated and the untreated hippocampus/EC for each participant. Asymmetry is presented at baseline (a) and post-treatment (b). Changes of asymmetry(c) are presented as percentage change between the baseline and post-treatment ratios of uptake value.